Synopsis: This white paper discusses the challenges of obtaining the data needed to conduct research, drawn from interviews with pharmaceutical and hospital researchers. It explains why Q-Centrix is uniquely positioned to support pharmaceutical and life sciences organizations by providing high-quality data sets purpose-built for their research needs, enabling them to accelerate the discovery of new treatments.
Details:
Real world data are immensely valuable in pharmaceutical research—but between data quality issues and inconsistencies in data preparation, obtaining large volumes of high-quality data from hospitals is a significant challenge for researchers.
Our new white paper discusses the barriers to obtaining data sets for research, shares insights from pharmaceutical and hospital researchers, and explains why Q-Centrix is uniquely positioned to support pharmaceutical and life sciences organizations by providing high-quality data sets purpose-built for their research needs.
By working with one standardized clinical data management partner, study sponsors can bypass the typical research roadblocks and pave the way for faster advancements in treatment development.
This guide is for:
- Study sponsors at pharmaceutical and life sciences organizations who need a reliable source of high-quality data sets for research
- Pharmaceutical leaders looking for strategies to advance research more efficiently
